Advertisement
CPAY vs HCAT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPAY is a Hold and HCAT is a Hold.
CPAY in upward trend: 10-day moving average crossed above 50-day moving average on October 30, 2026
The 10-day moving average for CPAY crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on CPAY as a result. In 49 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for CPAY just turned positive on November 02, 2026. Looking at past instances where CPAY's MACD turned positive, the stock continued to rise in 27 of 35 cases over the following month. The odds of a continued upward trend are 77%.
CPAY moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +9.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPAY advanced for three days, in 235 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 177 of 270 cases where CPAY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
CPAY broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 31 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CPAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.287) is normal, around the industry mean (16.722). P/E Ratio (26.847) is within average values for comparable stocks, (53.333). Projected Growth (PEG Ratio) (0.757) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.371) among similar stocks. P/S Ratio (5.528) is also within normal values, averaging (103.889).
HCAT's Indicator enters downward trend
The Aroon Indicator for HCAT entered a downward trend on October 28, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 293 similar instances where the Aroon Indicator formed such a pattern. In 265 of the 293 cases the stock moved lower. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HCAT as a result. In 80 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for HCAT turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 42 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
HCAT moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HCAT crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HCAT's RSI Oscillator exited the oversold zone, 30 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 50-day moving average for HCAT moved above the 200-day moving average on October 30, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
HCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.120) is normal, around the industry mean (4.793). P/E Ratio (-0.408) is within average values for comparable stocks, (13.685). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.429) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. HCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
CPAY | HCAT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 31 | 100 | |
SMR RATING 1..100 | 33 | 99 | |
PRICE GROWTH RATING 1..100 | 41 | 64 | |
P/E GROWTH RATING 1..100 | 9 | 15 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCAT's Valuation (38) in the null industry is in the same range as CPAY (70) in the Miscellaneous Commercial Services industry. This means that HCAT’s stock grew similarly to CPAY’s over the last 12 months.
CPAY's Profit vs Risk Rating (31) in the Miscellaneous Commercial Services industry is significantly better than the same rating for HCAT (100) in the null industry. This means that CPAY’s stock grew significantly faster than HCAT’s over the last 12 months.
CPAY's SMR Rating (33) in the Miscellaneous Commercial Services industry is significantly better than the same rating for HCAT (99) in the null industry. This means that CPAY’s stock grew significantly faster than HCAT’s over the last 12 months.
CPAY's Price Growth Rating (41) in the Miscellaneous Commercial Services industry is in the same range as HCAT (64) in the null industry. This means that CPAY’s stock grew similarly to HCAT’s over the last 12 months.
CPAY's P/E Growth Rating (9) in the Miscellaneous Commercial Services industry is in the same range as HCAT (15) in the null industry. This means that CPAY’s stock grew similarly to HCAT’s over the last 12 months.
| CPAY | HCAT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 63% | 2 days ago 68% |
| Stochastic ODDS (%) | 2 days ago 57% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 64% | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 86% |
| TrendWeek ODDS (%) | 2 days ago 71% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 69% | 2 days ago 88% |
| Advances ODDS (%) | 2 days ago 67% | N/A |
| Declines ODDS (%) | 10 days ago 65% | 4 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 69% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 66% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CPAY’s FA Score shows that 3 FA rating(s) are green while HCAT’s FA Score has 1 green FA rating(s).
- CPAY’s FA Score: 3 green, 2 red.
- HCAT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CPAY’s TA Score shows that 6 TA indicator(s) are bullish while HCAT’s TA Score has 4 bullish TA indicator(s).
- CPAY’s TA Score: 6 bullish, 4 bearish.
- HCAT’s TA Score: 4 bullish, 6 bearish.
Price Growth
CPAY (@Computer Communications) experienced а +12.32% price change this week, while HCAT (@Services to the Health Industry) price change was -16.20% for the same time period.
The average weekly price growth across all stocks in the @Computer Communications industry was +1.07%. For the same industry, the average monthly price growth was -10.70%, and the average quarterly price growth was -3.77%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.63%. For the same industry, the average monthly price growth was -2.00%, and the average quarterly price growth was +9.74%.
Reported Earning Dates
CPAY is expected to report earnings on Feb 10, 2027.
HCAT is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Computer Communications (+1.07% weekly)Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.
@Services to the Health Industry (-1.63% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
Advertisement
CPAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, CPAY has been loosely correlated with HUBS. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CPAY jumps, then HUBS could also see price increases.
| Ticker / NAME | Correlation To CPAY | 1D Price Change % | ||
|---|---|---|---|---|
| CPAY | 100% | +6.78% | ||
| HUBS - CPAY | 63% Loosely correlated | -5.39% | ||
| SSNC - CPAY | 63% Loosely correlated | -1.59% | ||
| ADSK - CPAY | 62% Loosely correlated | -0.34% | ||
| CRM - CPAY | 61% Loosely correlated | -2.07% | ||
| PCOR - CPAY | 60% Loosely correlated | N/A | ||
More | ||||
HCAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.
| Ticker / NAME | Correlation To HCAT | 1D Price Change % | ||
|---|---|---|---|---|
| HCAT | 100% | -5.66% | ||
| KVYO - HCAT | 47% Loosely correlated | -2.57% | ||
| EVCM - HCAT | 46% Loosely correlated | -2.00% | ||
| RDVT - HCAT | 45% Loosely correlated | -9.85% | ||
| CPAY - HCAT | 43% Loosely correlated | +6.78% | ||
| COIN - HCAT | 43% Loosely correlated | -9.69% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FFUT | 61.15 | 0.73 | +1.21% |
| Fidelity Managed Futures ETF (FFUT) | |||
| THYM | 49.12 | 0.21 | +0.44% |
| T. Rowe Price High Income Municipal ETF (THYM) | |||
| NIM | 9.21 | -0.04 | -0.40% |
| Nuveen Select Maturities Municipal Fund | |||
| SOUX | 3.83 | -0.13 | -3.39% |
| Defiance Daily Target 2X Long SOUN ETF (SOUX) | |||
| BFLX | 24.45 | -1.13 | -4.41% |
| iShares Flexible Equity Active ETF (BFLX) | |||